151 related articles for article (PubMed ID: 9344606)
1. Monitoring uptake of ellipticine and its fluorescence lifetime in relation to the cell cycle phase by flow cytometry.
Sailer BL; Valdez JG; Steinkamp JA; Darzynkiewicz Z; Crissman HA
Exp Cell Res; 1997 Oct; 236(1):259-67. PubMed ID: 9344606
[TBL] [Abstract][Full Text] [Related]
2. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence lifetime-based discrimination and quantification of cellular DNA and RNA with phase-sensitive flow cytometry.
Cui HH; Valdez JG; Steinkamp JA; Crissman HA
Cytometry A; 2003 Mar; 52(1):46-55. PubMed ID: 12596251
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric fluorescence lifetime analysis of DNA-binding probes.
Sailer BL; Steinkamp JA; Crissman HA
Eur J Histochem; 1998; 42 Spec No():19-27. PubMed ID: 10076766
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced with different cycle-perturbing agents produces differential changes in the fluorescence lifetime of DNA-bound ethidium bromide.
Sailer BL; Valdez JG; Steinkamp JA; Crissman HA
Cytometry; 1998 Mar; 31(3):208-16. PubMed ID: 9515720
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
[TBL] [Abstract][Full Text] [Related]
7. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.
Larsen AK; Paoletti J; Belehradek J; Paoletti C
Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block.
Vilarem MJ; Charcosset JY; Primaux F; Gras MP; Calvo F; Larsen CJ
Cancer Res; 1985 Aug; 45(8):3906-11. PubMed ID: 4016757
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in human promyelocytic leukemia HL-60 cells by Ampelopsis cantoniensis crude extract.
Tan TW; Tsai HY; Chen YF; Chung JG
In Vivo; 2004; 18(4):457-62. PubMed ID: 15369184
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of RNA content in different cell populations using pyronin Y and methyl green.
Pollack A; Prudhomme DL; Greenstein DB; Irvin GL; Claflin AJ; Block NL
Cytometry; 1982 Jul; 3(1):28-35. PubMed ID: 6180873
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
12. DNA cell cycle analysis of K562 and Ehrlich tumor cells by flow cytometry.
Radu DL; Dolganiuc A; Olinescu A
Roum Arch Microbiol Immunol; 1996; 55(3):193-203. PubMed ID: 9256021
[TBL] [Abstract][Full Text] [Related]
13. Interpreting cell cycle effects of drugs: the case of melphalan.
Lupi M; Cappella P; Matera G; Natoli C; Ubezio P
Cancer Chemother Pharmacol; 2006 Apr; 57(4):443-57. PubMed ID: 16195878
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of interactions between U-937 human macrophages and positively charged catanionic vesicles.
Kuo JH; Chang CH; Lin YL; Wu CJ
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):307-13. PubMed ID: 18353620
[TBL] [Abstract][Full Text] [Related]
15. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
Traganos F; Kapuscinski J; Darzynkiewicz Z
Cancer Res; 1991 Jul; 51(14):3682-9. PubMed ID: 2065324
[TBL] [Abstract][Full Text] [Related]
16. Ellipticine-induced changes in cell growth and nuclear morphology.
Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
J Natl Cancer Inst; 1980 Dec; 65(6):1329-36. PubMed ID: 6933278
[TBL] [Abstract][Full Text] [Related]
17. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule.
Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP
Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604
[TBL] [Abstract][Full Text] [Related]
18. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
19. Interactions of intercalating fluorochromes with DNA analyzed by conventional and fluorescence lifetime flow cytometry utilizing deuterium oxide.
Sailer BL; Nastasi AJ; Valdez JG; Steinkamp JA; Crissman HA
Cytometry; 1996 Oct; 25(2):164-72. PubMed ID: 8891446
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of HL-60 promyelocytic leukemia cells: simultaneous determination of phagocytic activity and cell cycle distribution by flow cytometry.
Blair OC; Carbone R; Sartorelli AC
Cytometry; 1986 Mar; 7(2):171-7. PubMed ID: 3456296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
